FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3670011000001106: Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25904501000001111 Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25904601000001110 Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Is a Cilazapril 1mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Is pack of Vascace 1mg tablets (Roche Products Ltd) false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has active ingredient Cilazapril false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has active ingredient Cilazapril monohydrate false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has AMP Vascace 1mg tablets (Roche Products Ltd) true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilazapril true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Cilazapril monohydrate false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Cilazapril monohydrate true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has basis of strength substance Cilazapril true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start